CID 1091543

4-morpholineacetamide, n-(5-methyl-1,3,4-thiadiazol-2-yl)-

Structural Information

Molecular Formula
C9H14N4O2S
SMILES
CC1=NN=C(S1)NC(=O)CN2CCOCC2
InChI
InChI=1S/C9H14N4O2S/c1-7-11-12-9(16-7)10-8(14)6-13-2-4-15-5-3-13/h2-6H2,1H3,(H,10,12,14)
InChIKey
VVFXNWLPOPZNHQ-UHFFFAOYSA-N
Compound name
N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-morpholin-4-ylacetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

242.08374 Da
Monoisotopic Mass

0.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 243.09102 152.5
[M+Na]+ 265.07296 158.9
[M-H]- 241.07646 155.7
[M+NH4]+ 260.11756 166.5
[M+K]+ 281.04690 157.6
[M+H-H2O]+ 225.08100 144.1
[M+HCOO]- 287.08194 166.0
[M+CH3COO]- 301.09759 189.4
[M+Na-2H]- 263.05841 153.8
[M]+ 242.08319 151.9
[M]- 242.08429 151.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.